Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Pricing
SKY Learn

Sector: Pharmaceuticals & Biotechnology

Small Cap

Aptus Pharma Share Price

Aptus Pharma Ltd.

₹342.20

-6.95(-1.99%)

Trade Now

1st Apr 2026 | 10:15 AM

NSE :

Open Free Demat Account

Aptus Pharma Performance

Price Movement

N/A

₹342.20

₹345.05

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹345.05

Low₹342.20

Open at₹342.20

Prev Close₹349.15

Volumes8.00 K

Avg Price₹342.91

Lower Circuit₹342.20

Upper Circuit₹356.10

Historical Performance

3M High₹364.00

3M Low₹162.75

1 Yr High₹364.00

1 Yr Low₹80.80

3 Yr High₹364.00

3 Yr Low₹80.80

5 Yr High₹364.00

5 Yr Low₹80.80

Aptus Pharma Fundamentals

Market Cap

Below industry Median

239.50 Cr.

PE Ratio (TTM)

High in industry

77.30

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

2% decr over last year

44.49

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

High in industry

MFI

MFI strongly Overbought

94.27

RSI

RSI Overbought

72.90

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

Aptus Pharma Financials

Data not available for chart

Indicator
No Record Found

Aptus Pharma Technicals

Aptus Pharma Ltd. EMA & SMA

₹342.20

-14.05 (-3.94%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹346

Day EMA10 ₹334.9

Day EMA12 ₹330.3

Day EMA20 ₹313.8

Day EMA26 ₹303.3

Day EMA50 ₹269.8

Day EMA100 ₹214.1

Aptus Pharma Support and Resistance

Resistance

First Resistance₹349.15

Second Resistance₹349.15

Third Resistance₹349.15

Support

First Support₹349.15

Second Support₹349.15

Third Support₹349.15

Technical Indicators

Day RSI72.90

Day MFI94.27

Day ADX51.59

Day Commodity Channel Index86.80

William-16.10

Day MACD27.02

Day MACD Signal Line24.52

Day ATR9.94

Day ROC125-

Day ROC2138.91

Aptus Pharma Shareholding Pattern

Held By	Sep 2025	Dec 2025
Promoter	72.9	72.9
FII	10	0
DII	2.8	0
Public	14.3	27.1

Aptus Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2 K	2 K	100.00%
Week	7 K	7 K	100.00%
1 Month	10 K	10 K	100.00%
6 Month	30.25 K	33.41 K	90.53%

Aptus Pharma SWOT Analysis

Strengths17

Weakness6

Opportunity0

Threats0

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with reducing Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Aptus Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Aptus Pharma Stock Comparison

Financials	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.
Price (₹)	₹217	₹36.87	₹5.54	₹99.90	₹101.40
% Change	4.35%	1.99%	4.92%	7.48%	1.59%
Revenue TTM (₹ Cr)	-	₹0.54	₹83.60	-	₹282.74
Net Profit TTM (₹ Cr)	-	₹-0.24	₹-34.95	-	₹15.30
PE TTM	60.10	-91.90	-1.30	12.30	25.30
1 Year Return		703.33	428	-27.38	-20.79
ROCE	-	-	-5.63	-	-

Similar Stocks

AHCL

Anlon Healthcare Ltd.

₹ 114.80

+3.07%

MEDISTEP

Medistep Healthcare Ltd.

₹ 16.50

+0.00%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 65.00

+5.38%

APL

Asston Pharmaceuticals Ltd.

₹ 75.00

+2.74%

INFLUX

Influx Healthtech Ltd.

₹ 214.00

+5.94%

MEDIORG

Medicamen Organics Ltd.

₹ 22.15

+4.98%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 504.00

+2.10%

ASTONEALAB

Astonea Labs Ltd.

₹ 150.00

-2.02%

AMWILL

Amwill Health Care Ltd.

₹ 30.39

+4.97%

SENORES

Senores Pharmaceuticals Ltd.

₹ 780.00

+2.69%

INNOVACAP

Innova Captab Ltd.

₹ 707.25

+2.52%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 57.45

+11.29%

SHELTER

Shelter Pharma Ltd.

₹ 26.99

+0.60%

TLL

Trident Lifeline Ltd.

₹ 271.90

+1.32%

DPL

Dipna Pharmachem Ltd.

₹ 8.60

+7.23%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.70

+8.16%

FABINO

Fabino Enterprises Ltd.

₹ 15.94

+4.94%

SUPRIYA

Supriya Lifescience Ltd.

₹ 606.50

+7.94%

SIGACHI

Sigachi Industries Ltd.

₹ 18.89

+11.64%

WINDLAS

Windlas Biotech Ltd.

₹ 774.05

+5.06%

VINEETLAB

Vineet Laboratories Ltd.

₹ 29.74

+2.34%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 30.50

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 460.00

+8.10%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.43

+7.50%

FAQ's on APPL

What is the Market Capitalization of Aptus Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 30 March 2026, the market cap for Aptus Pharma Ltd. is approximately ₹ 239.5 Cr.

What are the PE and PB ratios for Aptus Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Aptus Pharma Ltd. is 77.3, and the Price-to-Book (PB) ratio is 11.

What is the 52-Week High and Low for Aptus Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Aptus Pharma Ltd. shares was ₹ 364, and the lowest price was ₹ 80.8.

Who are the major shareholders of Aptus Pharma Ltd.?

Significant shareholdings in Aptus Pharma Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Aptus Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Aptus Pharma Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy